Tirzepatide 50MG is a 50-milligram format of tirzepatide, a synthetic peptide studied for its dual activity at GIP and GLP 1 receptors. Research has examined tirzepatide in the context of incretin signalling, glucose metabolism pathways, and energy balance regulation. Its sequence incorporates non natural residues and lipidation that are commonly investigated for effects on peptide stability and receptor engagement.

Tirzepatide 5MG is a 5-milligram format of tirzepatide, a synthetic peptide studied as a dual incretin receptor agonist in metabolic research. Researchers have investigated tirzepatide in models examining glycemic control, appetite signaling, and body weight regulation.